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The  immunological  memory  that  develops 
during T cell–dependent (TD) immune responses 
comprises populations of plasma cells and recir-
culating antigen-experienced B and T lympho-
cytes (Tarlinton, 2006). Two compartments of 
humoral  memory,  plasma  cells  and  memory   
B cells, are generated in germinal centers (GCs) 
that develop within the secondary lymphoid 
organs during TD responses (Tarlinton, 2006). 
Although composed primarily of B lympho-
cytes, GCs contain small numbers of CD4+  
T cells, dendritic cells, and macrophages and 
develop in association with antigen localized 
on  the  surface  of  follicular  dendritic  cells 
(Haberman and Shlomchik, 2003; Allen et al., 
2007). After a period of B cell proliferation, 
several processes are initiated within the GC 
that affect affinity maturation whereby the mean 
binding affinity of antigen-specific antibody in-
creases as a function of time (MacLennan, 1994; 
Allen et al., 2007). Affinity maturation is driven 
in  large  part  by  the  somatic  hypermutation 
(SHM) of the immunoglobulin V genes of pro-
liferating GC B cells, a process which is medi-
ated by the enzyme activation-induced cytidine 
deaminase (AID). B cells expressing antigen re-
ceptors of improved affinity, usually as a result 
of SHM, are preserved preferentially. Iterations 
of proliferation, mutation, and avidity-based 
selection improve the mean affinity of the re-
sponding B cell population (MacLennan, 1994; 
Allen et al., 2007).
Normally, in an immune response to a   
protein antigen the vast majority of memory   
B cells and bone marrow plasma cells arise from 
the  somatically  diversified  affinity-matured 
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Germinal centers (GCs) are sites of B cell proliferation, somatic hypermutation, and selection 
of variants with improved affinity for antigen. Long-lived memory B cells and plasma cells 
are also generated in GCs, although how B cell differentiation in GCs is regulated is unclear. 
IL-21, secreted by T follicular helper cells, is important for adaptive immune responses, 
although there are conflicting reports on its target cells and mode of action in vivo. We 
show that the absence of IL-21 signaling profoundly affects the B cell response to protein 
antigen, reducing splenic and bone marrow plasma cell formation and GC persistence and 
function, influencing their proliferation, transition into memory B cells, and affinity  
maturation. Using bone marrow chimeras, we show that these activities are primarily a  
result of CD3-expressing cells producing IL-21 that acts directly on B cells. Molecularly,  
IL-21 maintains expression of Bcl-6 in GC B cells. The absence of IL-21 or IL-21 receptor 
does not abrogate the appearance of T cells in GCs or the appearance of CD4 T cells with  
a follicular helper phenotype. IL-21 thus controls fate choices of GC B cells directly.
© 2010 Zotos et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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requirement of IL-21 may be in the GC reaction, on which 
cell types it may act, and what its activities might be. This 
uncertainty  has  been  heightened  by  recent  publications   
suggesting that IL-4 is a key mediator of Tfh activity (King 
and Mohrs, 2009; Reinhardt et al., 2009).
Given the multitude of potential roles for IL-21 on lympho-
cyte behavior (Ettinger et al., 2008), we wished to assess the   
development of a humoral immune response in mice lacking 
IL-21 or the IL-21R. These experiments confirmed a role for 
IL-21 in the formation of plasma cells, contradicted a mandatory 
autocrine role for IL-21 in Tfh development or function, and 
revealed a previously undefined role for this cytokine in the   
GC reaction and the regulation of their output. These actions of 
IL-21 on B cells were direct, as they were replicated by the   
selective absence of the IL-21R on B cells and not on T cells, 
suggesting that the major activity of IL-21 in the GC is on B cells 
and is not to establish or maintain cells of a Tfh phenotype.
RESULTS
IL-21 is required for normal plasma cell formation
Previous experiments have shown that IL-21 can act as a po-
tent inducer of immunoglobulin class switch recombination 
and B cell differentiation in both human and mouse B cells 
(Ettinger et al., 2008). We therefore examined the develop-
ment and localization of antibody-secreting cells (ASCs) in 
spleen and bone marrow of IL-21R/ and IL-21/ mice 
after immunization with a TD antigen delivered i.p. in alum 
and compared this with the response of C57BL/6 (control) 
mice. 7 d after immunization, the frequency of antigen-
  specific IgG1 ASC in the spleens of control mice was signifi-
cantly higher than in either IL-21R/ or IL-21/ mice 
(Fig. 1 A, left). These IgG1 ASCs were located in and around 
the bridging channels in spleen sections of day-7 immunized 
mice, although at reduced frequency in mutant spleens (Fig. 1 B 
and not depicted). The frequency of NP-specific IgG1 ASC 
in the spleens of all strains declined between days 7 and 28, 
with approximately two- to threefold more remaining in   
the spleens of control mice compared with IL-21R/ and 
IL-21/ mice at day 28. We also examined IgE production 
in response to immunization and, as expected from previous 
studies (Ozaki et al., 2002), found this to be elevated (Fig. S1). 
Affinity maturation among splenic ASC was assessed by deter-
mining the proportion of secreting antibody capable of bind-
ing a low-level haptenation plate coat (Roes and Rajewsky, 
1993). At day 28, the proportion of NP-specific ASC that was 
of high affinity in the spleens of IL-21/ and IL-21R/ 
mice was significantly reduced compared with control mice 
(Fig. 1 A, right), suggesting a defect in affinity maturation.
To assess GC-derived ASC, we examined the frequency 
of NP-specific IgG1 ASC in the bone marrow (Fig. 1 C), a 
site enriched in GC-derived plasma cells (Smith et al., 1997; 
Takahashi et al., 1998). The mean frequency of NP-specific 
IgG1 ASC in the knockout mice was less than in control mice 
at both 14 and 28 d after immunization, reaching statistical 
significance at the later time. The proportion of NP-specific 
ASC secreting high-affinity IgG1, however, was significantly 
population of GC B cells (Tarlinton, 2006). It is inferred that 
avidity for antigen is a major determinant in plasma cell dif-
ferentiation of GC B cells, whereas memory B cell formation 
is more influenced by survival (Lanzavecchia and Sallusto, 
2002; Phan et al., 2006; Tarlinton, 2006). It also appears that 
both types of post-GC B cell are produced throughout the 
GC reaction rather than being released into the circulation in 
a single event (Blink et al., 2005). The persistence and con-
tinued activity of GC, which is indicated by the continued 
production of plasma cells and memory B cells and the   
increasing frequency of V gene mutation, implies that a   
proportion of GC B cells remain within the GC and undergo 
additional rounds of proliferation, mutation, and selection 
(MacLennan, 1994; Allen et al., 2007). B cells within GC 
therefore have several possible fates: death, division with or 
without SHM, or differentiation into either the memory 
B cell or plasma cell compartments.
GC  persistence,  development,  and  function  absolutely 
require CD4+ T cells. T cells activated by antigen-presenting 
dendritic cells migrate into the B cell area in part as a result   
of their up-regulation of CXCR5, a chemokine receptor 
normally restricted to B cells (Allen et al., 2007). Indeed, the 
expression of CXCR5 contributes to the definition of what 
are now called T follicular helper (Tfh) cells (Vinuesa et al., 
2005). In addition to CXCR5, Tfh cells are distinguished 
from other CD4 T cells by their elevated expression of ICOS 
and CD40L (Vinuesa et al., 2005), both of which are critical 
for the initiation and maintenance of the GC (Tarlinton, 
2006). Intriguingly, up-regulation of many of the molecules 
that define the Tfh phenotype appears to be mediated by 
Bcl-6, which is required for their development in a cell-intrinsic 
manner (Johnston et al., 2009). Tfh cells are also enriched for 
secretion of IL-21 (Chtanova et al., 2004; Nurieva et al., 
2008) and IL-4 (Reinhardt et al., 2009). IL-21 is associated 
with growth and differentiation of many types of lympho-
cytes, including B and T cells (Ettinger et al., 2008). The   
effects of IL-21 on B cells vary depending on the context. In 
vivo, IL-21R deficiency leads to a state of pan-hypogamma-
globulinaemia  while  promoting  high  titers  of  IgE  (Ozaki   
et al., 2002). In vitro, IL-21 has been shown to increase both 
Blimp-1 and Bcl-6 in B cells (Ozaki et al., 2004; Arguni   
et al., 2006), suggesting an ability for IL-21 to influence mul-
tiple aspects of B cell differentiation. Recent data support the 
notion  that  IL-21  has  a  critical,  possibly  obligatory,  role   
in the development of Tfh cells and, through this, on the 
formation of GC (Nurieva et al., 2008; Vogelzang et al., 
2008), whereas other data suggest a less universal association 
(Linterman et al., 2009). IL-21 has also been shown to aug-
ment the formation of Th17 cells (Korn et al., 2007; Nurieva 
et al., 2007; Zhou et al., 2007), which have been shown to 
both secrete IL-21 and promote GC formation in a mouse 
model of autoimmunity (Hsu et al., 2008), strengthening the 
view that the effects of IL-21 on GC activity are T cell medi-
ated. An earlier study, however, using IL-21R–deficient 
mice reported GC and memory development to be normal 
(Ozaki et al., 2002), raising uncertainty as to exactly what the JEM VOL. 207, February 15, 2010 
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A GC abnormality in the absence of IL-21 signaling
The  reduced  frequency  and  affinity  of  NP-specific  bone   
marrow plasma cells indicated a possible GC abnormality in 
the immune response of IL-21/ and IL-21R/ mice. We 
therefore investigated GC formation in spleen by immuniz-
ing mice as before and determining both the distribution of 
lower in the bone marrow of IL-21/ and IL-21R/ mice 
than in C57BL/6 at both day 14 and day 28 after immuniza-
tion (Fig. 1 C, right). Thus, IL-21 has a role in two aspects of 
ASC development after immunization: in the expansion of early 
extrafollicular ASC in spleen and in the production of high-
affinity ASC resident in the bone marrow.
Figure 1.  Loss of IL-21 or IL-21R affects plasma cell formation after TD immunization. (A) The frequency of NP-specific IgG1 ASC among  
splenocytes from IL-21/, IL-21R/, and C57BL/6 mice, immunized i.p. with NP-KLH in alum, was assessed by ELISpot at the indicated times after  
immunization. The results are presented as ASC per million splenocytes (left). At day 28, the ratio of high-affinity (NP2 binding) to total (NP13 binding) 
IgG1 NP-specific ASC was determined using differentially haptenated plate coats (right). (B) Immunohistochemical staining of spleen sections from 
C57BL/6 and IL-21R/ mice at day 7 after immunization. Blue is B220, identifying B cell follicles (F), and red is IgG1, revealing foci of plasma cells  
(arrows) in C57BL/6 spleens with few in IL-21R/ spleens. IgG1 staining in follicles marks presumptive immune complexes within GCs. Bars, 100 µm.  
(C) After immunization, NP-specific IgG1 ASCs appear in the bone marrow of both C57BL/6 and IL-21/IL-21R/ mice but accumulate only in controls 
(left), whereas affinity maturation also occurs only in control mice (right) as measured by ELISpot using differentially haptenated plate coats. Results  
are derived from at least three experiments with 4–10 mice per time point per genotype. Error bars for ELISpot frequency (left) and ratio (right) are SEM. 
Differences were examined using a Student’s t test and only marked if significant.368 IL-21 sustains germinal center B cells | Zotos et al.
Figure 2.  Intrafollicular response in IL-21– and IL-21R–deficient mice. (A) Representative spleen histology staining revealing the localization  
of NP-reactive cells (blue) 7 d after immunization in control and IL-21R/ mice. B cells follicles were stained with IgD (brown). GCs are indicated, as are 
foci of ASC (open arrows). NP-reactive B cells in follicles are shown by closed arrows in expanded region. Bars, 100 µm. (B) Quantification of the histology 
staining shown in A from C57BL/6, IL-21/, and IL-21R/ mice of NP-specific plasmablasts (PBs) and plasma cells (PCs) in the red pulp and NP-specific 
B cell blasts in the follicles. (C) Flow cytometric scheme for the analysis of antigen-specific B cells in the spleens of NP immunized mice. Spleen cells were  
partitioned into isotype-switched B cells, and the percentage of those cells that were IgG1+ and NP binding was determined to calculate the fraction of 
total spleen involved in the B cell response. Values shown are the percentage of events displayed and not overall splenic frequencies. (D) Frequency  
distribution of antigen-reactive B cells in the spleen after immunization of C57BL/6, IL-21/ and IL-21R/ mice. (E) Total spleen cell number of antigen-
reactive B cells in C57BL/6, IL-21/, and IL-21R/ mice after immunization at the times indicated. Data in D and E are representative of at least three 
independent experiments of between 5 and 11 mice at each time point. Error bars are ± SEM. Differences were examined using a Student’s t test and  
only marked if significant. (F) Representative appearance of GC in the spleen by immunohistochemistry, 14 d after immunization, from C57BL/6, IL-21/,  
and IL-21R/ mice. GC was revealed with PNA (blue). Follicles (F) revealed with B220 (red). Bars, 100 µm.JEM VOL. 207, February 15, 2010 
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antigen-specific  cells  by  immunohistochemistry  and  their   
frequency by flow cytometry (Fig. 2). Resolving the location 
and nature of NP-reactive B cells revealed substantial differ-
ences between knockout and control mice. Although NP-
specific cells were identified as ASC in bridging channels and 
in GC within follicles in spleens of all mice 7 d after immuni-
zation, there was an unusual accumulation of NP-binding   
B cell blasts in the follicular mantles of the knockout strains 
(Fig. 2, A and B; and Fig. S2 B). Parenthetically, this staining 
revealed NP-specific cells irrespective of isotype, showing 
that the deficiency in ASC in the knockout spleens shown in 
Fig. 1 is a defect in development and not in isotype switching. 
NP staining also revealed an unexpected role for IL-21 in 
migration of antigen-activated B cells early in the immune 
response. Despite their aberrant localization, the frequency 
and total number of NP-specific B cells in spleens of immu-
nized IL-21– and IL-21R–deficient mice at day 7 were   
approximately equal to those in control mice (Fig. 2, C–E). 
In fact the representation of NP+IgG1+ B cells in the spleens 
of the different groups was similar at all times examined, up 
Figure 3.  Accelerated formation of memory B cell compartment in IL-21– and IL-21R–Deficient Mice. (A) Representative flow cytometric  
plots resolving GC and memory compartments among NP-specific B cells in spleens of C57BL/6 and IL-21R/ mice 28 d after immunization. Splenocytes,   
previously gated to include only isotype-switched B cells, were assessed for expression of IgG1 and binding of NP (left). Expression of CD38 on NP+IgG1+ 
B cells resolved memory (CD38hi) and GC (CD38lo) B cells (right). The percentages are the proportion of displayed events falling within the indicated  
NP+IgG1+ and CD38hi gates. (B) Proportion of NP-specific B cells with a memory phenotype at times indicated after immunization of C57BL/6, IL-21/, 
and IL-21R/ mice. (C) Absolute numbers of NP-specific IgG1 memory B cells in spleens of C57BL/6, IL-21/, and IL-21R/ mice at the indicated times 
after immunization. Symbols in B and C indicate the mean of between 5 and 11 mice at each time point, ± SEM, and derived from at least three  
independent experiments. Differences were examined using a Student’s t test and only marked if significant.370 IL-21 sustains germinal center B cells | Zotos et al.
Tfh development in IL-21–deficient mice
The abnormal development of ASC and GC in IL-21/ and 
IL-21R/ mice raised the question of the nature of the T cell 
help in these mice (Nurieva et al., 2008; Vogelzang et al., 2008). 
We examined spleens of immunized control, IL-21/, and 
IL-21R/ mice for CD4+ T cells coexpressing CXCR5 and 
PD1, a combination of markers which is widely used in identi-
fying Tfh cells (Vinuesa et al., 2005), and found such cells in all 
groups, albeit at somewhat variable frequency at the time points 
assessed (Fig. 4, A and B). Interpreting the frequency of Tfh in 
IL-21 knockout mice, however, is complicated by the GC 
B cell phenotype in these mice and the possibility that Tfh de-
velopment,  persistence,  or  localization  is  influenced  by  the 
presence of GC B cells. We therefore used histology to deter-
mine if CD3+ cells were in fact located within the GC of IL-
21–deficient mice at day 14. Such cells were clearly visible and   
appeared to be distributed equivalently with those in controls 
(Fig. 4 C). These results suggest that although IL-21 may have 
a role in Tfh expansion or persistence, it is not required for their 
appearance, localization, or ability to support GC formation.
Attenuated V gene mutation and selection in the absence 
of IL-21
To  determine  if  the  premature  dissolution  of  GC  and   
expansion of memory B cells in mice deficient for IL-21 or 
IL-21R might alter the incidence of SHM among those 
memory B cells, single NP-specific IgG1+ memory B cells 
(B220+NP+IgG1+CD38hi) were isolated from the spleens 
of  IL-21/,  IL-21R/,  and  control  mice  28  d  after   
immunization. RNA was extracted from these single cells, 
complementary DNA (cDNA) synthesized, and rearrange-
ments  involving  VH186.2  and  C1  amplified  by  PCR,   
this being the dominant rearrangement in the response of 
C57BL/6  mice  to  NP  (Cumano  and  Rajewsky,  1985). 
Comparing the sequence of these amplified transcripts to 
the  germline  VH186.2  sequence  revealed  a  significant   
reduction  in  the  proportion  of  knockout  NP-specific 
memory B cells carrying mutated VH genes, in the mean 
frequency of SHM, and in the proportion of VH186.2 genes 
carrying the affinity enhancing exchange of tryptophan for 
leucine at position 33 (Table I). The significance of the   
to day 53 (Fig. 2, D and E; and not depicted). Despite the 
early differences in NP-specific B cell location, GC histology 
in day-14 immunized knockout and control mice was very 
similar (Fig. 2 F), but by day 28 after immunization, GC in 
the IL-21/IL-21R/ spleens were markedly smaller than 
those in controls (Fig. S2, C and D).
The discrepancy between histologically reduced GC at 
day 28 yet similar numbers of NP-reactive B cells in the 
spleen was reconciled by resolving NP-specific IgG1+ B cells 
into  GC  and  memory  compartments  using  expression  of 
CD38 (Oliver et al., 1997; Ridderstad and Tarlinton, 1998) 
measured by flow cytometry (Fig. 3 A). These analyses   
revealed the proportion of NP-specific B cells with a mem-
ory phenotype to increase in control mice from <10% at day 
14 to 20% at day 28 (Fig. 3 B), which is consistent with 
other examples of this immunization protocol (Takahashi 
et al., 2001). Memory B cell representation in the IL-21 and 
IL-21R knockout spleens, which was already significantly 
increased at day 14 compared with controls, reached >70% of 
antigen-specific B cells by day 28 (Fig. 3 B). The absolute 
number of NP+IgG1+ memory B cells in the knockout mice 
was significantly different from controls at days 14 (IL-21 and 
IL-21R) and 28 (IL-21R), despite not increasing over that 
period (Fig. 3 C). Thus, the increasing representation of 
memory B cells seen by flow cytometry in immunized IL-21 
and IL-21R knockout mice was a result of the accelerated 
loss of GC B cells, as indicated by histology. Importantly, the 
memory B cells formed in the knockout strains persisted and 
were functional, in that boosting at day 53 with soluble anti-
gen increased the frequency of ASC (Fig. S3). The formation 
of GC in the absence of IL-21R or IL-21 supports a previous 
study (Ozaki et al., 2002) and contradicts others (Nurieva   
et al., 2008; Vogelzang et al., 2008), whereas the subsequent 
premature dissolution reveals a unique role for IL-21 signal-
ing in the maintenance of GC. In considering whether other 
potential Tfh cytokines had effects similar to those of IL-21, 
we  immunized  IL-4–deficient  mice.  These  mice  showed 
proportions of GC and memory B cells similar to controls   
at all time points measured, albeit at significantly reduced   
frequencies (Fig. S4), suggesting distinct roles for IL-21 and 
IL-4 in the GC (Reinhardt et al., 2009).
Table I.  Distribution of VH gene somatic mutation in IL-21/ and IL-21R/ memory B cells
Genotype VH186.2 VH186.2+a Unmutated Position 33 
mutationb
VH mutation 
frequency
Excluding germline sequences
Position 33 W→Lb VH mutation 
frequency
% (number) % (number) %
C57BL/6 4 24 8 (2) 54 (13) 5.1 ± 3.1 59 5.55 ± 2.8
IL-21/ 1 12 42 (5) 8 (1)# 1.7 ± 2.5** 14# 2.86 ± 2.8#
IL-21R/ 3 28 61 (17) 7 (2)* 1.0 ± 1.9** 18# 2.64 ± 2.2**
The VH mutation frequency is shown as mean mutation per VH gene. The VH mutation frequency ranges are the following: C57BL/6, 0–8; IL-21/, 0–9; IL-21R/, 0–7.  
#, P < 0.05; *, P < 0.005; **, P < 0.001.
aSequences from single cell PCR were analyzed exactly as previously described (Blink et al., 2005) to define VH186.2 and mutations.
bPercentage of sequences containing mutations that results in an amino acid replacement of tryptophan with leucine at position 33.JEM VOL. 207, February 15, 2010 
Article
371
enrichment for, or selection against, amino acid replacements 
in  the  CDRs  and  the  framework  regions,  respectively 
  (unpublished data). Reduced affinity maturation in the memory 
compartment of IL-21R/ mice was also apparent in the 
lower frequency of high-affinity ASC produced after boost 
immunization (Fig. S3). Thus, immunization of IL-21/ and 
IL-21R/ mice produced memory B cell compartments that 
reduced frequency of SHM or representation of tryptophan 
at VH position 33 in the knockout memory B cells was not 
reversed by excluding germline sequences from the analysis 
(Table I). It appeared, therefore, that memory B cells in the 
IL-21/ and IL-21R/ mice had not undergone as many 
rounds of mutation and selection as those in controls. The 
groups did not differ significantly in the degree of either 
Figure 4.  IL-21 is not essential for Tfh cell development. (A) Representative flow cytometry gating for identifying Tfh cells among splenocytes. 
CD4+TCR-+ cells were assessed for expression of PD1 and CXCR5 to resolve Tfh cells in C57BL/6 and IL-21/ mice. Percentages are of the CD4+TCR-+ 
population. (B) Frequency of Tfh cells (CD4+TCR-+PD1+CXCR5+) in C57BL/6, IL-21/, and IL-21R/ mice at times indicated after immunization. Values 
are mean frequency of two to six mice per time point from at least two experiments and error bars are ± SD. (C) Immunohistochemical staining of CD3+ 
cells (blue) in the GCs of the spleens from day 14 immunized C57BL/6 and IL-21R/ mice. The example shown is representative of at least four mice  
from two experiments for each genotype. B cell follicles were revealed with IgD (brown). Bars, 100 µm.372 IL-21 sustains germinal center B cells | Zotos et al.
of CD3+ cells to secrete IL-21 and a failure of GC B cells to 
bind the IL-21, respectively. Collectively these data show that 
IL-21 mediates its GC effects by acting directly on B cells and 
not via a T cell subset.
Maintenance of B cell proliferation in GC requires IL-21R
We next determined if the loss of GC B cells in the absence of 
IL-21R was associated with altered proliferation by quantify-
ing the fraction of such B cells in cell cycle at varying times   
after immunization. Control and IL-21R/ mice, immunized 
with NP-KLH in alum 7, 14, or 21 d earlier, were sacrificed 
and the isotype switched, and NP-binding immunoglobulin 
light chain lambda (1
+) B cells were purified from spleen by 
cell sorting after magnetic enrichment for 1
+ B cells (Fig. 6 A), 
which together with VH186.2 comprises the canonical anti-
NP BCR in C57BL/6 mice (Cumano and Rajewsky, 1985). 
The representation of 1
+ B cells among splenocytes from 
control and IL-21R/ mice at these times ranged from 2.0 ± 
0.2 to 1.6 ± 0.4% (mean ± SEM) with no significant differ-
ences. NP-specific GC (CD38lo) B cells were identified by 
flow cytometry as indicated (Fig. 6 A) and the proportion of 
these cells in cell cycle (DNA content > 2n) determined by 
staining  the  nuclei  with  propidium  iodide.  There  was  no   
significant difference in the proportion of antigen-specific GC 
B cells in cell cycle in IL-21/ compared with control mice 
at day 7 (Fig. 6 B). By day 14, however, a significant differ-
ence was apparent between the two groups with a mean of 
<20% of IL-21/ GC B cells in cell cycle compared with 
40% in controls (Fig. 6 B). This difference persisted through   
to day 21 (Fig. 6 B). Diminished proliferation of IL-21R–
  deficient GC B cells was observed using the alternative approach 
of measuring BrdU incorporation into antigen-specific B cells 
at days 7, 14, and 28 after immunization (Fig. S6). Thus, in the 
absence of IL-21 signaling, GC B cell proliferation was cur-
tailed significantly at later time points.
DISCUSSION
This paper confirms a requirement for IL-21 in the efficient 
formation of early ASC (Ozaki et al., 2002; Ettinger et al., 
2008; Odegard et al., 2008) and extends these results to show 
an  important  role  for  this  cytokine  in  the  persistence  of   
GC. This function of IL-21 was revealed by the accelerated 
resolution of the GC reaction with a concomitant premature 
formation of an antigen-specific memory B cell compartment 
in mice lacking either IL-21R or IL-21. This effect was, im-
portantly, mediated by IL-21 acting directly on GC B cells 
and was not replicated by loss of IL-4. The accelerated disso-
lution of GC in the absence of IL-21 binding to its receptor 
also affects the bone marrow ASC compartment, which is 
not unexpected given that these cells also originate in the 
GC. As a consequence when compared with controls, the 
bone marrow plasma cell compartment was underpopulated 
and significantly reduced in affinity maturation in the mutant 
mice, which is consistent with its formation having been pre-
maturely curtailed. Analysis of GC B cell proliferation at dif-
ferent time points in the immune response in IL-21 mutant 
were less mutated and less stringently selected for affinity than 
controls, a difference which may contribute to the reduced af-
finity maturation among plasma cells (Fig. 1).
IL-21 acts directly on B cells
The abnormalities in the immune response of intact IL-21/ 
and IL-21R/ mice did not distinguish between IL-21 acting 
directly on the B cells or having an effect via, for example, Tfh 
or Th17 cells, both of which are known to respond to and 
produce IL-21 and both of which are implicated in GC de-
velopment (Hsu et al., 2008; Nurieva et al., 2008; Vogelzang 
et al., 2008). To resolve the impact of IL-21 on B cells and 
T cells, a series of chimeric mice were made by reconstituting   
irradiated  IL-21R/  or  IL-21/  recipients  with  mixtures   
of donor bone marrow (Fig. 5, A and D). In the first series,   
IL-21/ and IL-21R/ recipients were reconstituted with a 
4:1 mixture of CD3/ and Ly5.1, CD3/ and IL-21/, 
or CD3/ and IL-21R/ bone marrow such that CD3 
T cells in these mice were Ly5.1 WT, unable to secrete IL-21, 
or lacked the IL-21R, whereas the vast majority of other leuko-
cytes were WT. 8 wk after reconstitution, mice were immu-
nized with NP-KLH in alum and the frequency of NP-specific 
B cells was determined at days 14 and 28 of the response   
(Fig. 5 B). Although the overall B cell response to NP was 
similar  in  all  groups,  declining  by  an  equivalent  degree   
between days 14 and 28, the distribution of NP-specific   
B cells into the GC and memory compartments was strikingly 
different. As in the intact IL-21–deficient mice (Fig. 2), there 
was a near threefold increase in the representation of memory 
B cells at day 28 compared with controls in the CD3//
IL-21/ chimeras in which the T cells were unable to   
secrete IL-21. The CD3//IL-21R/ group, in which   
T cells lacked the IL-21R, showed a slight, albeit significant, 
increase over controls (Fig. 5 C). Despite the ability of NKT 
cells to secrete IL-21 (Harada et al., 2006), they were ruled 
out as the source of IL-21 through analysis of TCR J18/ 
immunized mice (Fig. S5).
In separate experiments, irradiated mice were reconsti-
tuted with a 1:1 mixture of Ly5.1 control and Ly5.2 IL-21R–
deficient bone marrow and were thus chimeric for IL-21R+/+ 
(Ly5.1) and IL-21R/ (Ly5.2) lymphocytes (Fig. 5 D). These 
mice were immunized and the relative contribution of the 
two types of B cells to the immune response was determined 
by flow cytometry (Fig. 5 E). Control and IL-21R/ B cells 
were present among the total NP-reactive IgG1+ B cell popu-
lation at days 14 and 28 at near 50:50 ratios, reflecting the 
chimerization of naive B cells. The proportion of NP+IgG1+ 
B cells with a CD38hi memory phenotype, however, was near 
threefold increased among the IL-21R/ B cells at day 28, 
compared with the control IL-21R+/+ NP+IgG1+ B cells in 
the same spleens (Fig. 5 F). Thus, the loss of GC B cells seen 
in intact IL-21R/ mice was replicated in mixed chimeras in 
which the B cells lacked the IL-21R but not in chimeras in 
which T cells were IL-21R deficient. These chimera experi-
ments show conclusively that the GC phenotype apparent in 
intact IL-21/ and IL-21R / mice is the result of a failure JEM VOL. 207, February 15, 2010 
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Memory in the absence of IL-21
An intriguing aspect of the formation of B cell memory in 
the absence of IL-21 is the prevalence of unmutated VH gene 
sequences among the memory B cells, raising the possibility 
mice revealed it to be initially normal but to then diminish 
significantly  in  a  later  stage  of  the  response.  Collectively, 
these data provide a unique insight into the means by which 
T cells sustain and regulate GC B cell behavior.
Figure 5.  Radiation chimeras show IL-21 acts directly on B cells. (A) Production of chimeric mice with IL-21 or IL-21R deficiency restricted to the  
T cells. Irradiated recipients were reconstituted with a 1:4 ratio of IL-21R/ and CD3/, IL-21/ and CD3/, or WT and CD3/ bone marrows and 
subsequently immunized with NP-KLH in alum. (B) Symbols depict the frequency of NP+IgG1+ B cells in individual chimeric mice at the indicated time  
in the presence of WT T cells, IL-21/ T cells, and IL-21R/ T cells. Mean is indicated by the bar and data are from two independent experiments. (C) The 
proportion of memory cells among the NP+IgG1+ B populations shown in B. (D) Production of chimeric mice reconstituted with a 1:1 ratio of C57BL/6 
(Ly5.1) and IL-21R/ (Ly5.2) bone marrow cells. (E) Frequency of NP+IgG1+ B cells in individual mice, partitioned according to Ly5 allotype (IL-21R status) 
at the indicated times with mean shown by the bar. Data are from two independent experiments. (F) The proportion of the NP-specific B cells shown in  
E with a CD38hi memory phenotype. Significant differences were determined by a Student’s t test and are indicated.374 IL-21 sustains germinal center B cells | Zotos et al.
Figure 6.  Loss of IL-21 signaling reduces B cell proliferation in GCs. (A) Representative flow cytometric plots for the identification and isolation of 
NP-specific B cells within the spleens of immunized mice. Spleen cells were enriched for Ig lambda (1) expression using magnetic separation then frac-
tionated into isotype switched B cells and the percent of Ig+ NP binding among those cells determined. Expression of CD38 was used to differentiate 
germinal GC (CD38lo) from memory B cells (CD38hi) and gates for sorting NP-specific GC B cells set accordingly. (B) Proportion of GC B cells (NP++CD38lo) 
cells in (S + G2) phase in C57BL/6 and IL-21/ mice at times indicated. Values are derived from two experiments and are the mean of between three and 
eight mice (±SD) at each time. Significant difference at day 14 was determined by a Student’s t test. Day-21 data for IL-21–deficient mice are from a pool 
of three animals because low numbers of GC B cells prevented individual analysis.
that these B cells never entered into or remained within 
the GC for any extended period. When coupled with the 
early appearance of memory phenotype B cells and the mis-
localization of antigen-specific B cells in the mantle zone 
early in the response, the lack of mutations may indicate an 
alternate route for memory formation for a portion of the 
responding B cells. Germline isotype-switched memory B 
cell compartments have been reported in mice reconstituted 
with Bcl-6–deficient bone marrow (Toyama et al., 2002) 
and  in  mice  treated  shortly  after  immunization  with  an 
ICOS antagonistic antibody (Inamine et al., 2005). In both 
cases, the germline memory was considered to have arisen 
from antigen-driven B cell expansion outside GCs. It is in-
triguing to speculate that the NP+IgG1+ B cells carrying 
unmutated VH genes at day 28, seen in both the IL-21 and 
IL-21R mutant mice, are derived from the NP+ cells lo-
cated in the mantle zone early in the response, cells which 
were Bcl6 negative (unpublished data). Why, in the ab-
sence of IL-21, a fraction of reactive B cells are mislocalized 
is an intriguing question. B cells exposed to antigen initially 
migrate to the T cell border, where they receive signals 
from  antigen-activated  CD4  T  cells  that  promote  their   
further migration to either the bridging channels as plasma-
blasts or their reentry to the follicles for the formation of 
GC (Batista and Harwood, 2009). Recently, the orphan   
G protein–coupled receptor Ebi2 (also called GPR183) has 
been shown to have an important role in this bifurcation, as 
its up-regulation is associated with extrafollicular plasma-
blast formation and down-regulation with B cell localization 
on follicular dendritic cells (Gatto et al., 2009). Interestingly, 
Ebi2 is repressed by Bcl6 (Shaffer et al., 2001), itself a target 
of IL-21 in B cells (Ozaki et al., 2004; Arguni et al., 2006). 
It may be that early in an immune response, the absence of 
IL-21 reduces the prevalence of Ebi2 up-regulation among 
antigen-reactive B cells, leaving such cells in the follicles 
with the appearance of non–GC-derived memory. Consis-
tent with that, GC B cells from IL-21 deficient mice con-
tain  less  Bcl6  messenger  RNA  (mRNA)  and,  in  vitro, 
exposure to IL-21 reduces Ebi2 mRNA in CD40L-stimu-
lated B cells (Fig. S6).JEM VOL. 207, February 15, 2010 
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a requirement for IL-21 in the formation of CD4+ CXCR5+ 
Tfh cells (Nurieva et al., 2008; Vogelzang et al., 2008), iden-
tified as being the T cells within the GC (Vinuesa et al., 
2005). These studies show that in the absence of IL-21 or its 
receptor, development of Tfh is diminished and GC do not 
arise after immunization. Interestingly, the original study on 
IL-21R/ mice (Ozaki et al., 2002) detected GC after im-
munization and we found CD4+ T cells with the phenotype 
of Tfh in mice incapable of IL-21 signaling (Fig. 4). Two 
possible reasons for the discrepancy between our GC results 
and those published earlier are differences in the formulation 
of antigen (alum in our case rather than sheep red blood cells 
or CFA) and kinetics. The fact that we observe Tfh develop-
ment in the absence of IL-21 shows clearly that any de-
pendency  is  not  universal.  We  also  find  Tfh  and  GC  in 
IL-21–deficient mice infected with influenza virus (unpub-
lished data), as have others using different viruses (Yi et al., 
2009). We also find that the B cell response in IL-21R/ 
mice immunized with sheep red blood cells shows acceler-
ated resolution of GC, as reported in this paper with alum 
(unpublished data), indicating that time is a critical variable in 
these analyses and that the phenotype revealed here required 
the identification and tracking antigen-specific B cells. Thus, 
although IL-21 does not act on Tfh development, differenti-
ation, or activation, it may act on their expansion or persis-
tence and has a critical role in regulating GC B cells.
In this paper we identify IL-21 as a T cell–derived factor 
that is required for the maintenance of GC. It would seem a 
logical extension of the results presented in this paper that 
naturally  occurring  variation  in  either  the  production  of   
IL-21 or sensitivity to its binding may alter the outcomes of 
immunization and immune responses. Heightened IL-21 sig-
naling on B cells may be associated with prolonged periods 
within the GC with a concomitant extended period of expo-
sure to AID activity, which may lead to the accumulation of 
excessive somatic mutations, some of which may contribute 
to transformation (Jankovic et al., 2007). Additionally, a sur-
feit  of  IL-21  signaling  may  inhibit  differentiation  within   
the GC leading to diminished memory. Conversely, too little 
IL-21  signaling  may  replicate  aspects  of  the  situation  de-
scribed in this paper in which memory may be formed but 
with inadequate affinity maturation. Regulating IL-21 pro-
duction and signaling, therefore, will be crucial in achieving 
an appropriate level of affinity maturation in immune mem-
ory compartments.
MATERIALS AND METHODS
Mice, immunization, and tissue recovery. All mutant mice were 8–12 
generations backcrossed onto the C57BL/6 background. IL-21 receptor-
  deficient (IL-21R/; provided by W. Leonard, National Heart, Lung and 
Blood Institute, Bethesda, MD), IL-21 ligand-deficient (IL-21/; provided 
by ZymoGenetics Inc., Seattle, WA), and IL-4 ligand-deficient (IL-4/; 
The Jackson Laboratory) mice were bred and maintained in the specific 
pathogen-free facilities of the Peter MacCallum Cancer Centre (Melbourne, 
Australia).  TCR  J18/  mice  (Cui  et  al.,  1997)  were  maintained  at   
University of Melbourne. C57BL/6 mice used in immunization cohorts 
were  similarly  housed.  Reconstitution  experiments  used  donor  bone   
marrow from T cell–deficient (CD3/; Malissen et al., 1995) and Ly5.1 
GC activity incorporating the role of IL-21 in B cell behavior
Data presented in this paper are consistent with IL-21 having 
a key role in maintaining GC B cell proliferation and regulat-
ing differentiation. Within the GC, B cell proliferation and 
differentiation are typically assigned to distinct regions and 
distinct cell types, dark and light zones, and centroblasts and 
centrocytes,  respectively.  There  are  relatively  few  known 
molecules that distinguish between these zones and cell types. 
Bcl6  is  highest  in  centroblasts,  which  are  proliferating   
and mutating, and lowest in centrocytes (Falini et al., 2000; 
Cattoretti et al., 2006). IRF4, induced by CD40 stimulation 
in GC B cells and able to directly repress Bcl-6 transcription 
(Saito et al., 2007), is apparently restricted to centrocytes in 
established GC (Cattoretti et al., 2006). Although such differ-
ences between GC cell types presumably facilitate the unique 
biological activities within each, it is somewhat less clear what 
drives the interchange between centroblast and centrocyte. 
Centrocytes are considered the GC B cells that undergo   
differentiation, being out of cell cycle and in proximity to 
CD4+ T cells, which deliver the stimuli that promote survival, 
proliferation, and differentiation. The enhanced memory for-
mation, diminished GC B cell proliferation, and premature 
GC dissolution observed in the IL-21 mutants may indicate a 
role for IL-21 in promoting the transition of centrocytes to 
centroblasts. Using CXCR4 expression as a marker, we found 
normal  proportions  of  centroblasts  and  centrocytes  among 
GC B cells in IL-21 mutants at all times examined (unpub-
lished data), which argues against this transition being blocked 
in the absence of IL-21. Similarly, we did not observe in-
creased apoptosis among GC B cells in our analysis of cell 
cycle distribution. Our data support at a minimum the con-
clusion that IL-21 acts to enhance GC B cell proliferation, 
which is consistent with IL-21’s reported activity on B cells in 
vitro (Ettinger et al., 2008). The role of IL-21 in the genera-
tion of plasma cells is not yet resolved. The extrafollicular 
plasma cell deficiency could be the cumulative effect of   
reduced proliferation, differentiation, as previously reported 
(Odegard et al., 2008), or even altered migration. Bone mar-
row plasma cell defects could be accounted for by the prema-
ture termination of the GC reaction rather than defective 
differentiation or selection by themselves.
IL-21 and the development of Tfh
An alternative explanation for the GC defect in IL-21 defi-
cient mice is that IL-21 is required for the induction or func-
tion of a CD4 T cell subset that is essential for GC maintenance 
or activity. IL-21 has been shown through in vitro experi-
ments to be capable of generating Th17 cells, which have 
been shown to secrete IL-21 along with IL-17 (Korn et al., 
2007; Nurieva et al., 2007; Zhou et al., 2007). Although 
there is uncertainty about the stringency of the requirement 
for IL-21 in the formation of Th17 in vivo (Coquet et al., 
2008; Sonderegger et al., 2008), it is possible that this T cell 
subset may influence GC function, as IL-17 has been shown 
to influence GC B cell activity in at least one mouse strain 
(Hsu et al., 2008). Of greater relevance are studies describing 376 IL-21 sustains germinal center B cells | Zotos et al.
Proliferation of GC B cells. At the times indicated, NP+CD38lo GC B 
cells in spleen were identified using a modification of the staining protocol 
described in the previous section and sorted on a FACS-Aria (BD). Anti-IgG1 
staining was replaced with anti-Ig staining (Jc5; biotin) allowing magnetic 
bead preenrichment of Ig-expressing B cells using anti-biotin microbeads 
and separation of labeled cells over a MACS LS column, according to the 
manufacturer’s protocol (Miltenyi Biotec). Streptavidin-Cy5 (SouthernBio-
tech) was used for staining of Ig+ cells for FACS sorting. Between 25,000 
and 100,000 GC B cells were sorted per mouse, washed, and resuspended in 
200 µl of PI Buffer (0.1% sodium acetate with 0.2% Triton X-100, 10 µg/ml 
RNase A, and 50 µg/ml propidium iodide). Cells were vortexed twice for   
10 s, incubated at room temperature for 20 min in the dark, and then ana-
lyzed on a Canto II or LSR II flow cytometer (BD) with a minimum of 5,000 
events recorded. FlowJo version 8.8.2 cell cycle analysis software (Tree Star, 
Inc.) was used to analyze data.
Online supplemental material. Fig. S1 shows the total serum IgE levels 
and NP-specific IgE levels in C57BL/6, IL-21/, and IL-21R/ mice after 
immunization. Fig. S2 demonstrates the effect of IL-21 and IL-21R signal-
ing on NP+ B cell localization. Fig. S3 shows memory B cell recall responses 
in the absence of IL-21 signaling. Fig. S4 compares WT mice and IL-4/ 
mice in their GC and memory B cell responses to a TD antigen. Fig. S5 
examines the role IL-21 secretion by NKT cells in the formation of GCs 
and memory B cells. Fig. S6 shows that the loss of IL-21R reduces B cell 
proliferation in vivo and that IL-21 reduces Ebi2 mRNA expression in   
B cells in vitro. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20091777/DC1.
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